On July 26, 2022, Curt A. Herberts III, the Chief Operating Officer of Senti Biosciences, Inc., a Delaware corporation (the Company), notified the Company of his decision to resign from his employment with the Company, effective as of August 19, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.261 USD | +6.40% |
|
+5.93% | -60.45% |
05-17 | Senti Biosciences, Inc. Announces Executive Changes | CI |
05-09 | Senti Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-60.45% | 11.94M | |
+15.19% | 121B | |
+19.91% | 114B | |
+18.34% | 23.61B | |
-19.80% | 20.43B | |
-15.68% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- SNTI Stock
- News Senti Biosciences, Inc.
- Senti Biosciences, Inc. Announces Resignation of Curt A. Herberts III, Chief Operating Officer Effective as of August 19, 2022